688520 神州细胞
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)36.950-48.82794.728224.112-475.870
总资产报酬率 ROA (%)1.8943.730-14.521-25.261-57.092
投入资产回报率 ROIC (%)2.2634.625-18.787-35.586-85.652

边际利润分析
销售毛利率 (%)94.87695.91397.11096.68994.761
营业利润率 (%)6.19122.6210.337-34.958-637.576
息税前利润/营业总收入 (%)16.3218.508-15.291-42.225-624.971
净利润/营业总收入 (%)12.3024.471-21.026-50.827-646.514

收益指标分析
经营活动净收益/利润总额(%)48.100442.2805.63675.009102.089
价值变动净收益/利润总额(%)0.4781.126-0.624-1.174-1.125
营业外收支净额/利润总额(%)49.673-405.929101.60431.2231.383

偿债能力分析
流动比率 (X)0.7340.7260.5231.1160.885
速动比率 (X)0.6060.5970.4230.9760.750
资产负债率 (%)94.24695.891122.285108.852116.822
带息债务/全部投入资本 (%)88.00985.421114.83269.03598.459
股东权益/带息债务 (%)7.8796.131-24.270-16.601-27.002
股东权益/负债合计 (%)6.2834.474-18.032-7.946-14.120
利息保障倍数 (X)4.0622.108-2.667-4.908-29.010

营运能力分析
应收账款周转天数 (天)125.12073.10860.37460.424218.568
存货周转天数 (天)914.314810.0351,302.1971,496.6883,297.920